Exenatide

141758-74-9

CS-O-01461

C₁₈₄H₂₈₂N₅₀O₆₀S

4186.6

NC([C@H](CO)NC([C@@H]1CCCN1C([C@@H]2CCCN2C([C@@H]3CCCN3C([C@@H](NC(CNC([C@H](CO)NC([C@H](CO)NC([C@@H]4CCCN4C(CNC(CNC([C@H](CC(N)=O)NC([C@H](CCCCN)NC([C@H](CC(C)C)NC([C@@H](NC([C@H](CCC(O)=O)NC([C@@]([C@H](CC)C)([H])NC([C@@H](NC([C@H](CC(C)C)NC([C@H](CCCNC(N)=N)NC([C@H](C(C)C)NC([C@@H](NC([C@H](CCC(O)=O)NC([C@H](CCC(O)=O)NC([C@H](CCC(O)=O)NC([C@@H](NC([C@H](CCC(N)=O)NC([C@H](CCCCN)NC([C@H](CO)NC([C@H](CC(C)C)NC([C@@H](NC([C@H](CO)NC([C@@]([C@@H](C)O)([H])NC([C@@H](NC([C@@]([C@@H](C)O)([H])NC(CNC([C@H](CCC(O)=O)NC(CNC([C@@H](N[H])CC5=CN=CN5)=O)=O)=O)=O)=O)CC6=CC=CC=C6)=O)=O)=O)CC(O)=O)=O)=O)=O)=O)=O)CCSC)=O)=O)=O)=O)C)=O)=O)=O)=O)CC7=CC=CC=C7)=O)=O)=O)CC8=CNC9=C8C=CC=C9)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)C)=O)=O)=O)=O)=O

Therapeutic

Exenatide

Store at refrigerator (2-8°C) for long term storage

L-histidyl-glycyl-L-alpha-glutamyl-glycyl-L-threonyl-L-phenylalanyl-L-threonyl-Lseryl-L-alphaaspartyl-L-leucyl-L-seryl-L-lysyl-L-glutaminyl-L-methionyl-L-alphaglutamyl-L-alpha-glutamylL-alpha-glutamyl-L-alanyl-L-valyl-L-arginyl-L-leucyl-Lphenylalanyl-L-isoleucyl-L-alphaglutamyl-L-tryptophyl-L-leucyl-L-lysyl-L-asparagylglycyl-glycyl-L-prolyl-L-seryl-L-seryl-glycylL-alanyl-L-prolyl-L-prolyl-L-prolyl-Lserinamide

CAS
PubChem
Wikipedia

His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2

anti-diabetic;Exenatide-d5 Acetate is labelled Exenatide Acetate which causes an increase in acinar cAMP without stimulating amylase release. Exenatide has found use as a medication of diabetes II. Pugazhenthi; U, et al,: Diabetol,; 53; 2357 (2010); Li; C, et al,: Bioche;, Biophys, Res, Comm,; 400; 563 (2010); Lupi; R, et al,: Diab, Obes, Metab,; 10; 515 (2008); Kim; T,H, et al,: Bioconj, Chem,; 22; 625 (2011);"

Not less than 95%

Refer MSDS for complete information.